Stephanie Krebs
Net worth: - $ as of 2026-06-29
Net worth: - $ as of 2026-06-29
Stephanie Krebs is currently Chief Business Officer at Sensei Biotherapeutics, Inc. since 2023.
Formerly, Ms. Krebs was Chief Business Officer at SNIPR Biome ApS from 2022 to 2023.
Education includes graduate studies at The Johns Hopkins University, undergraduate studies at Rochester Christian University, and an MBA from the University of Rochester Simon Business School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 0 ( -.--% ) | - $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Corporate Officer/Principal | 2023-10-31 |
| Companies | Position | End |
|---|---|---|
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology Develops bacterial composition to provide treatment for diabetes to cancer | Corporate Officer/Principal | 2023-09-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Rochester Simon Business School
University of Rochester Simon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology Develops bacterial composition to provide treatment for diabetes to cancer | Health Technology |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Select your edition
All financial news and data tailored to specific country editions